Press Releases

Experiemental vaccines hold promise to slow the return of glioblastoma multiforme. UC Irvine begins enrolling patients in DCVax trial.

UC Irvine study patients with renal failure experienced changes the composition of intestinal bacterial microbes that are crucial to staving off disease-causing pathogens and maintaining micronutrient balance.

Efforts to treat disorders like Lou Gehrig’s disease, Paget’s disease, inclusion body myopathy and dementia will receive a considerable boost from a new research model created by UC Irvine scientists.

Epilepsy review by UC Irvine neurologist and colleagues shows that identification and treatment of psychiatric, cognitive and social comorbidities is necessary to enhance quality of care and quality of life.

UC Irvine and European scientists have found that increasing natural marijuana-like chemicals in the brain can help correct behavioral issues related to fragile X syndrome, the most common known genetic cause of autism.

Welcome Week facts and figures

Deva Ramanan is lauded for work boosting computers’ image recognition capabilities.

Researchers with UC Irvine’s Chao Family Comprehensive Cancer Center have identified a genetic pathway in melanoma cells that inhibits the cellular mechanism for detecting DNA damage wrought by chemotherapy, thereby building up tolerance to cancer-killing drugs.

UC Irvine scientists will be part of two research teams garnering CIRM Disease Team Therapy Development Awards, which are designed to accelerate collaborative translational research leading to human clinical trials.

UC Irvine study links repeated exposure to violent images from 9/11, Iraq War to acute and long-term stress symptoms.